This study is looking at a digital cognitive behavioral therapy (dCBT) called "Daylight dCBT Application" for people with generalized anxiety disorder (GAD) and cardiovascular disease (CVD). The goal is to see if this digital tool can help reduce anxiety symptoms in this group, as it can be hard for them to attend in-person therapy. Researchers will measure anxiety levels using the Generalized Anxiety Disorder Scale (GAD-7) after 10 weeks of treatment. The study plans to enroll 95 participants who are 18 or older, have experienced an acute CVD event (like a heart attack or stroke), and have significant GAD symptoms. The current recruitment status is unclear.

Study design

This interventional study will first assess the acceptability of the digital intervention in 5 participants, then randomize 90 individuals with acute CVD and GAD symptoms to either the Daylight dCBT Application or a waitlist control group.

What's involved

Participants will complete up to four modules of the digital intervention at their own pace. Assessments will occur at Week 0 (baseline), Week 3, Week 6, and Week 10 (post-treatment).

Compensation

Not stated in the trial record.

Follow-up

Anxiety levels will be measured at Week 10 (post-treatment).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.